04:37 PM EDT, 10/24/2024 (MT Newswires) -- Edwards Lifesciences ( EW ) reported Q3 adjusted earnings late Thursday of $0.67 per diluted share, up from $0.55 a year earlier.

Analysts polled by Capital IQ expected $0.59.

Net sales for the quarter ended Sept. 30 were $1.35 billion, up from $1.24 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.38 billion.

The company said it expects Q4 EPS to be between $0.53 and $0.57 on sales of $1.33 billion to $1.39 billion.

Analysts polled by Capital IQ expect $0.58 for GAAP and $0.60 for non-GAAP EPS on revenue of $1.40 billion.

The company said it repurchased $1 billion of stock in Q3 and has about $1.4 billion remaining in its current repurchase authorization.

Price: 75.75, Change: +5.40, Percent Change: +7.68